USA Proton Therapy Market to exceed USD 15 Billion

1
USA Proton Therapy Market Analyst View The
potential demand of proton therapy market in
United States for the year 2021 is expected to be
higher than USD 15 Billion, growing with a CAGR
of 6.04 percent. USA holds the major market share
in Global Proton Therapy Market.   Press Release
Title USA Proton Therapy Market to exceed USD
15 Billion by 2021, with CAGR of 6.04
Percent For More Information http//www.renub.co
m/usa-proton-therapy-market-to-exceed-usd-15-billi
on-by-2021-with-cagr-of-6-04-percent-23-nd.php

2
USA Proton Therapy Market to exceed USD 15
Billion by 2021, with CAGR of 6.04 Percent
Download Full Report http//www.renub.com/united
-states-proton-therapy-market-and-forecast-reimbur
sement-policy-patients-treated-at-proton-therapy-c
enters-1045-p.php
A new report by Renub Research, titled United
States Proton Therapy Market Forecast,
Reimbursement Policy and Patients Treated at
Proton Therapy Centers provides comprehensive
insight of United States Proton Therapy Market.
Proton therapy evolves as a prime radiation
treatment modality. The compliance of proton
therapy into clinical practice for more than 2
decades in United States makes it one of the
advanced radio therapy tool to fight deadly
cancerous tumor like Brain cancer, Eye cancer,
Prostate cancer, Colon and rectal cancer, Breast
cancer etc. In recent times, many research
institutes and hospitals are investing in proton
therapy to make proton therapy technology more
affordable and accessible to patients. Rising
cancer prevalence and increasing waiting list of
high risk cancer patients shows high credential
and acceptance of proton therapy in United
States.

3
USA Proton Therapy Market to exceed USD 15
Billion by 2021, with CAGR of 6.04 Percent
Proton Therapy is far better than Standard
Therapy   There was paradigm shift in terms of
utilization of radiotherapy over the several
decades and photons come into existence with
absence of randomized clinical trials. The
adoption of photons (radiotherapy) continues to
strive to limit the dose to normal tissues. The
core reason for this is the unable to control the
exit dose downstream from the target (tumor),
which is a physical limitation of the megavoltage
photon beam. Then, proton beam therapy (PBT) is
come under attention. Contrasting photons,
protons deposit almost all of their energy at a
defined and controllable depth from the skin
surface, specifically avoiding the exit dose.
Therefore it mitigates the risk of damage to
nearby healthy tissue and vanish negative side
effects.

4
USA Proton Therapy Market to exceed USD 15
Billion by 2021, with CAGR of 6.04 Percent
Proton Therapy provides Treatment Possibility for
Recurrent Lung Cancer in United
States According to recent study by
Multidisciplinary Thoracic Cancers Symposium, the
major death of cancer patients in United States
caused by lung cancer than any other type of
cancer, because of its Invasive form and
likelihood of recurrence. In historical facts,
recurrences have been exception to treat due to
majority of these patients are not opt for
surgery. The most patients with reoccurrence lung
cancer offered palliative options as a last
resort to manage pain. Proton therapy, permit
radiation oncologists to recognize normal tissues
and spare them while delivering escalated,
curative doses of radiation to nearby tumors.
Moreover, IMPT has ability to exactly target a
tumor.
5
USA Proton Therapy Market to exceed USD 15
Billion by 2021, with CAGR of 6.04 Percent
Medical Devices Report http//www.renub.com/medi
cal-devices-15-c.php

• Renub Research - North America
• Rajat Gupta
• 225 Kristie Ln, Roswell
• Georgia 30076, United States
• Tel [phone]
• Email info_at_renub.com
• www.renub.com
•  
• Renub Research - Asia
• Ankit Mishra
• C 86, Sector 10
• Noida 201301, India
• Tel [phone]
• Email info_at_renub.com